MeiraGTx Holdings plc
For the period ended Dec 31, 2024. Filed Mar 13, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 13, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information
During the three months ended December 31, 2024, none of our directors or “officers” (as defined in Rule 16a-1(f) under the Exchange Act)adopted, modified orterminated a “Rule 10b5-1 trading arrangement” and/or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
On March 13, 2025, our Board of Directors approved a waiver under the Company’s Code of Business Conduct and Ethics for Alexandria Forbes, Ph.D., President and Chief Executive Officer, approving Dr. Forbes’ participation on the Scientific Advisory Board of Hologen Limited and subscription of 100,000 shares of Hologen Limited for a nominal amount.
On March 13, 2025, our Board of Directors approved a waiver under the Company’s Code of Business Conduct and Ethics for Richard Giroux, Chief Financial Officer and Chief Operating Officer, approving Mr. Giroux’s participation on the Advisory Board of Hologen Limited and subscription of 50,000 shares of Hologen Limited for a nominal amount.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.